Atossa Genetics(美國(guó))

Atossa Genetics

美國(guó)AtossaGeneticswww.atossagenetics.com我們的個(gè)產(chǎn)品和服務(wù)是乳腺細(xì)胞吸取器檢測(cè)(MASCTSystem™).這個(gè)已經(jīng)美國(guó)國(guó)家食品衛(wèi)生檢驗(yàn)局許可的取樣及細(xì)胞測(cè)試系統(tǒng)只需10分鐘的取樣，且是無(wú)痛的。此項(xiàng)檢測(cè)可提早幾年偵測(cè)癌變細(xì)胞。我們透過(guò)研究及開(kāi)發(fā)，推出的創(chuàng)新產(chǎn)品和服務(wù)來(lái)協(xié)助醫(yī)護(hù)人員維持女性健康和福利。進(jìn)而預(yù)防、診斷及治療包括癌癥有關(guān)乳房的疾病。我們是一 家醫(yī)療保健公司專(zhuān)注于開(kāi)發(fā)和銷(xiāo)售為乳腺癌風(fēng)險(xiǎn)評(píng)估的新型細(xì)胞和分子診斷產(chǎn)品。Weareahealthcarecompanyfocusedonthedevelopmentandmarketingofnovelcellularandmoleculardiagnosticriskassessmentproductsforbreastcancer.Usingourpatented,FDA-approvedMammaryAspirateSpecimenCytologyTest(MASCT)System,anurseorphysician’sassistant,canpainlesslycollectasampleofNippleAspirateFluid(NAF)inabout10minutes.TheNAFsamplecontainscells(cytology)andmoleculardiagnosticbiomarkersthatareusefulinfindingcancersandpre-cancerouschanges,especiallyAtypicalDuctalHyperplasia(ADH),whichconfersahigherriskofdevelopingbreastcancer.TheFDAhasdetermined,basedonclinicaltrialdata,thattheMASCTS